OBJECTIVES: Determinant risk factors for developing protein losing enteropathy (PLE), including haemodynamics, remain unclear in patients after the Fontan operation.
INTRODUCTION
Protein losing enteropathy (PLE) is one of the most serious postoperative complications that has a powerful predictor for morbidity and mortality in patients after the Fontan operation [1, 2] . The haemodynamic characteristics in the PLE patients may consist of a high central venous pressure (CVP) and low cardiac output [cardiac index (CI)] [2] and a non-left ventricular morphology systemic ventricle, high preoperative systemic ventricular enddiastolic pressure (EDP), longer postoperative hospital stay and renal failure have been thought to be the predictors [1] . Infection may be a trigger of the onset of PLE [3] . Recent in vitro and in vivo studies demonstrated that a loss of heparan sulphate in the intestinal epithelial cells as well as inflammation plays a central role in the protein leakage from the gut [4] [5] [6] . However, clinical experience showing that only a small percentage of Fontan patients suffer from this disease had made clinicians seek other pathophysiological mechanisms for the development of PLE. An abnormal diminished mesenteric flow conjunction with chronic inflammation due to chronic heart failure syndrome has been proposed as one of the mechanisms of the development [7, 8] . When focussing on the haemodynamic issues, including the causative mechanisms, however, the only available data have been those obtained after the onset of PLE, which may not have confused the pathophysiological situation because the intensive treatment, such as a high dose of diuretics, may have significantly changed the haemodynamics. In this respect, we thought that our current strategy of a routine serial haemodynamic assessment [9] enabled us to clarify the pre-PLE haemodynamics, and furthermore, to identify the haemodynamic predictors.
METHODS

Subjects
We retrospectively reviewed a total of 406 patients (male in 245) with congenital heart disease who had undergone a Fontan operation and 21 Fontan patients (male in 14) from other hospitals who had been referred to our hospital for postoperative outpatient care. For this study, the last follow-up ended at the end of December 2010. Of those patients, we identified a total of 26 patients (6 from other hospitals) who had had a history of PLE. The clinical characteristics of the PLE patients are summarized in Table 1 . In our institute, all Fontan survivors had prospectively undergone periodic cardiac catheterizations before and 1, 5, 10, 15 and >20 years after the Fontan operation, except for some patients for social and/or medical reasons (9) . As of the end of December 2010, postoperative cardiac catheterization with cardiovascular imaging was performed in 406, 351, 260, 161, 92 and 32 patients before (within 6 months before the Fontan operation), and 1 (0.5-2.4), 5 (2.5-7.4), 10 (7.5-12.4), 15 (12.6-17.4 ) and 20 (17.6≥) years after the Fontan operation, respectively.
In 136 out of the 406 of our own Fontan patients who had undergone a complete serial cath-based haemodynamic assessment during the first 10 years, we identified 56 patients without a failing Fontan circulation who had no history of any clinical event that required hospitalization as a referent excellent Fontan group. In this study, we defined a failing Fontan circulation as that when a patient had at least one of following findings: (1) CVP ≥16 mmHg, (2) ventricular ejection fraction <40%, (3) atrioventricular valve regurgitation ≥ moderate, (4) arterial oxygen saturation <85%, (5) pulmonary vein obstruction and (6) one-lung Fontan circulation [10] . The Ethics Committee of the National Cardiovascular Center approved the study protocol. 
Haemodynamics and systemic ventricular performance
We measured the pressures in the cardiac chambers and great vessels, including the CVP and EDP. We estimated the oxygen consumption from the age, sex and heart rate and measured the CI (l/min/m 2 ) using the Fick principle with the assumption that the right and left pulmonary arterial saturations were equal in the patients with either a Glenn or total cavopulmonary connection because it is clinically difficult to measure an accurate flow distribution in the bilateral pulmonary arteries. We calculated the systemic and pulmonary arterial resistances and determined the systemic ventricular morphology angiographically as previously described [11] . We used Simpson's rule to estimate the right and left ventricular volumes and divided the end-diastolic ventricular volume by the body surface area to obtain the enddiastolic volume index (EDVI). We also calculated the systemic ventricular ejection fraction (EF).
Statistical analysis
For identifying PLE predictors, a univariate logistic regression model was used to detect the predictors of a PLE onset and when the variables had a P-value of <0.1, they were used for the multivariate logistic regression models to identify the independent predictors. We used clinical variables including the era of the Fontan operation, type of procedures, age at the time of the Fontan operation, heterotaxy syndrome, associated procedures before and at the time of the Fontan procedure and the 1-year postoperative haemodynamics. When the variables were statistically significant, the receiver operating characteristic curve analysis was applied to determine the cut-off values to identify an efficient prognostic value. The free rate from an onset of PLE and the survival rate after the onset were estimated using the Kaplan-Meier method and the differences in the event free status between the groups were assessed using log-rank tests. As for characterizing the PLE haemodynamics, a paired t test was used to determine the differences between before and after the onset of PLE for the haemodynamic comparisons and an unpaired t test to detect the differences between the patients with PLE and the referent excellent Fontan patients. The data are expressed as the mean ± SD. A P-value of <0.05 was considered statistically significant.
RESULTS
Risk factors and clinical profiles for developing protein losing enteropathy
The clinical characteristics are shown in Table 1 . Half (n = 13) of the PLE patients had at least one risk factor before the Fontan operation and 8 (35%) of the 23 patients who had a clinically relevant arrhythmia(s). Before the onset of PLE, a Fontan route stenosis (FRS) was demonstrated in 9 patients ( pulmonary vein obstruction, PVO, in 8 and atrioventricular valve stenosis in 1) and massive aortopulmonary collaterals to the left pulmonary artery, causing a reverse flow into the right pulmonary artery, were shown in 2. These 11 PLE patients were categorized as the FRS-PLE group. A reduced EF (<45%) and heart failure that required hospitalization were demonstrated in 6 and 2 patients, respectively, and clinically relevant arrhythmias occurred in 4 patients. These PLE patients were categorized as the cardiac-PLE group. Pulmonary arterio-venous fistulae (PAVF) were demonstrated in 3 patients (PAVF-PLE group, 12%) and 1 of them exhibited a reduced ventricular function (Fig. 1 , the inner circle). At the time of the onset of PLE, of the 11 FRS-PLE patients, a new onset of arrhythmias and heart failure occurred in 1 patient each. Of the 12 cardiac-PLE patients, a new arrhythmia and FRS were encountered in 2 and 1 patient, respectively. Of the 3 PAVF-PLE patients, 1 patient encountered a new arrhythmia (Fig. 1 , the outer circle). Thus, 6 (23%) of the 26 PLE patients had encountered a new additional pathophysiology at the time of the onset of PLE.z Management before and after the onset of protein losing enteropathy Table 2 summarizes the management before and after the onset of PLE and the high rate of medications indicated that our PLE patients were sicker than the usual Fontan patients. At the time of the PLE onset (acute phase), diuretics, heparin infusions, oxygen inhalation, albumin infusions, pulmonary artery dilators and steroids were given in 100, 65, 46, 42, 23 and 12% of the 26 patients, respectively. In addition, 8 surgical (3 conversions from an atriopulmonary connection to a total cavopulmonary connection, 3 re-Fontan operations and 2 atrioventricular valve In the chronic phase, 11 (79%) out of 14 patients who had undergone surgical and/or catheter intervention required the increase in diuretic dose. Pulmonary artery dilators (sildenafil and prostaglandin) were additionally given in 3 patients after the PLE onset, resulting in 6 patients with these dilators in total. All medication rates increased and a 2-fold increase in the diuretic dose (mg/kg) was observed (1.1 ± 1.0 vs 1.8 ± 0.8, P = 0.0041).
Of those managements, only 2 patients (8%) have become completely free from a relapse of PLE, i.e. 1 had benefited from a balloon dilatation 1 month after the PLE onset and the other from an atrioventricular valve replacement 9 months after the onset. However, the others have been suffering from the PLE and 5 (19%) patients eventually died, heart failure in 2 and sepsis, subarachnoidal haemorrhage and sudden death in 1 each.
Predictors for protein losing enteropathy and the survival after the onset of the protein losing enteropathy
The summary of the univariate and multivariate logistic regression analyses for the onset of PLE is shown in Table 3 . According to the univariate model, the 1-year postoperative CVP, preoperative functional one-lung circulation (PVO and massive aortopulmonary collaterals) (Fig. 2) and a non-left ventricular morphology systemic ventricle were associated with the onset of PLE. Of those, the functional one-lung circulation and high CVP independently predicted the onset of PLE (model 1). The receiver operating characteristic curve analysis revealed that 12 mmHg was the most efficient cut-off value of CVP, i.e. the risk of a future onset of PLE was 3.49 times higher in patients with a CVP ≥12 mmHg than in those with a CVP <12 mmHg (model 2) (Fig. 2) .
The survival after the PLE onset at 1, 5, 10 and 15 years was 96, 87, 62 and 62%, respectively (Fig. 3) .
Haemodynamic changes before and after the protein losing enteropathy onset and their comparison with those in the excellent Fontan survivors There were no differences in the age at the time of the Fontan operation between the PLE and the excellent groups (4.9 ± 3.9 vs 3.3 ± 3.3, P = 0.055). The percentages of non-left ventricular morphology systemic ventricle, atriopulmonary connection and heterotaxy syndrome for the PLE group were 22 (85%), 5 (19%) and 9 (35%), respectively, and the corresponding values for the excellent group were 31 (55%), 0 (0%) and 19 (34%), respectively. Fenestration was created in 2 and 3 for the PLE and the excellent groups, respectively.
The PLE occurred 6.5 ± 5.2 years (median 5.6, range 0.01-18.3 years) after the Fontan operation. Of the 26 PLE patients, 21 patients had undergone catheterizations before (−2.0 ± 1.8 years) and after (4.6 ± 4.1 years) the PLE onset (chronic phase) and the age at the time of each catheterization did not differ from that 5 and 10 years-postoperative catheterization in the excellent Tables 1 and 2. group, respectively. The haemodynamic changes before and after the PLE onset and a comparison with those in the excellent group are shown in Table 4 and Fig. 4 .
Central venous pressure
The CVP was higher in the PLE patients than in the excellent group (P < 0.0001). However, the pressure decreased in the chronic phase (P < 0.01), resulting in no difference between the groups. According to the PLE subgroup analysis, the CVP decreased in the FRS group (P < 0.05).
End-diastolic pressure
The EDP was higher in the PLE patients before the onset (P < 0.05); however, the pressure in the chronic phase did not differ from that in the excellent group. According to the PLE subgroup analysis, the pressure in the FRS group did not differ from that in the excellent group, while the pressure was significantly lower than that in the cardiac and the PAVF groups (P < 0.01).
Aortic pressure
The aortic (systemic) pressures before and after the onset of the PLE were lower in the PLE patients (P < 0.01 and P < 0.0001, respectively) and the pressure further decreased in the chronic phase (P < 0.05).
Cardiac index
There was no difference between the two groups before the onset of PLE. However, the cardiac index decreased significantly in the chronic phase of the PLE group (P < 0.05), resulting in no difference between the groups.
Arterial oxygen saturation
The saturation was lower before the onset of PLE in the PLE group (P < 0.0001). However, there was no difference in the chronic phase between the groups.
Pulmonary artery resistance
The resistance was higher before the onset of PLE in the PLE group (P < 0.05). However, there was no difference in the chronic phase between the groups.
Ventricular function
There was no difference in the EDVI between the groups. The preoperative EF (P < 0.05) and that before PLE onset (P < 0.001) were lower in the PLE group, while the postPLE EF did not differ from that in the excellent group.
DISCUSSION
There have been anecdotal beliefs that a high CVP has a little impact on the PLE onset and a low cardiac index leads to PLE; however, our study clearly demonstrated that the only pre-PLE Fontan haemodynamic predictor was a high CVP, especially ≥12 mmHg. In addition, a low systemic pressure was the only chronic PLE Fontan haemodynamic characteristics. Interestingly, a low cardiac index did not characterize PLE Fontan haemodynamics, or rather, the low cardiac index is one of the consequences after intensive PLE management. Therefore, we may have to minimize all CVP-raising risks, such as FRS, to prevent a new PLE onset. We also found that a PAVF was a newly recognized risk factor for developing PLE.
Haemodynamic characteristics of protein losing enteropathy patients
In the largest PLE report, the pulmonary artery pressure (16.3 ± 6.1 mmHg) and EDP (9.5 ± 5.6 mmHg) were high, while the cardiac index was similar to ours (2.4 ± 0.8 l/min/m 2 ) [2] . However, these available PLE haemodynamic data after the intensive management might have provided inaccurate and misleading information on haemodynamic risk factors for developing PLE. In this respect, our study is the first one to address the pre-PLE Fontan haemodynamic characteristics and the comparison with those of 'excellent survivors' could have further clarified the characteristics. In this setting, the most striking pre-PLE Fontan haemodynamic characteristics were high values of CVP and pulmonary artery resistance and low values of aortic pressure, arterial oxygen saturation and EF. Furthermore, a high CVP, especially ≥12 (mmHg), was a major haemodynamic culprit for the development of PLE. Interestingly, the pre-PLE cardiac index was similar to that in the excellent Fontan survivors, implying that a low cardiac index is not a main mechanism for developing PLE.
Central venous pressure raising haemodynamic factors
Our PLE patients were arbitrary divided into three groups based on the haemodynamic properties, i.e. FRS, cardiac and PAVF groups, and all of those characteristics could have increased the CVP. In the cardiac group, they were further divided into three groups, i.e. those with a low EF, those with atrioventricular valve regurgitation ≥ moderate and those with arrhythmias. The incidences of FRS and arrhythmias were 38 and 31%, respectively, which were similar to those in the previous study [2] . It is easily understandable that high values of EDP and high pulmonary artery resistance and massive aortopulmonary collaterals were responsible for the high CVP. Interestingly, a high CVP was also demonstrated in the PAVF group probably due to the high cardiac index and EDP, and we should be aware that a PAVF is a risk factor not only for hypoxia but also for developing PLE probably due to the high cardiac output situation. In addition, the PLE patients with arrhythmias had a low EF, indicating frequent marked increases in the CVP during tachyarrhythmias [12] . More interestingly, a late additional complication, such as an arrhythmia, may have triggered the onset of PLE in one quarter of our patients (Fig. 1) . We found that a low systemic pressure was the only postPLE haemodynamic character. A diminished mesenteric flow due to a low cardiac index has been thought to be involved in the PLE pathophysiology [8, 13] . Because a low systemic pressure as well as a high CVP may determine a high resistive index [14] , a low systemic pressure as a characteristic PLE haemodynamics does not contradict the high index [7] . Therefore, our evidences for the maintained cardiac index in the FRS group and the high cardiac index in the PAVF-PLE group contradict the idea of a low cardiac index-associated PLE development. Further studies are required to address this issue.
Inflammation may be another mechanisms for developing PLE [3, 13] . In fact, steroid therapy works in some PLE patients [15, 16] . However, we did not address the association of inflammation with the PLE development in the present study.
Prevention and management of protein losing enteropathy
According to our results, in addition to excluding high-risk patients with a functional one-lung circulation, all possible efforts should be applied to reduce a high CVP even if the clinical status is seemingly stable, especially in patients with a CVP ≥12 mmHg. In these respects, regarding the patient selection, we might have prevented our 9 patients from developing PLE (4 patients with PVO, 2 with massive aortopulmonary collateralls and 3 with poor ventricular function). As for strategies to decrease a high CVP, although the management strategies depend on the cause(s), catheter and/or surgical approaches need to be considered for subclinical FRS and atrioventricular valve dysfunction. If the pulmonary artery resistance is high, our current strategies may include new pulmonary artery dilators, such as sildenafil. However, this approach may be limited because current Fontan candidates, especially the high-risk patients, maximally benefit from those medication, indicating little additional benefits for the PLE resolution. Regarding ventricular dysfunction, we found 2 old-era PLE patients with a dyssynchronous contraction of the systemic ventricle and a cardiac resynchrony therapy may be applicable in our current practice [17] . We prescribed ß blocker and angiotensin converting enzyme inhibitor in some patients with a low EF; however, the efficacy remains unclear. On the other hand, once PLE occurred, an immediate approach to reduce the CVP may be mandatory because our 2 patients with complete PLE resolution were such cases. However, the precise mechanism for developing PLE still remains unknown and a time-dependent increase in the clinical complications, such as arrhythmias [18] , is inevitable. Therefore, because of a markedly low success rate of PLE treatment, surgical creation of atrial fenestration at the time of Fontan operation and/or the follow-up catheter re-dilatation for the closing fenestration may be necessary in high-risk patients [19] .
Survival after the onset of protein losing enteropathy
The survival seemed to be improved compared with that previously reported [1, 2] and was similar to that from a recent report [20] . Recent advances in medications for pulmonary artery dilators might provide a significant contribution to the improved survival when the elevated CVP was mainly due to a high pulmonary artery resistance.
Study limitations
First, the small number of our PLE patients was a significant study limitation in terms of statistical power. However, our current strategy of a prospective assessment provided us with a reasonable referent group, the excellent Fontan survivors, that could have clarified the haemodynamic characteristics in the PLE patients. Secondly, our cine-angiographical assessment of the ventricular function may have been inaccurate, especially that of the non-left ventricular morphology ventricle. More appropriate modalities, such as magnetic resonance imaging, should be needed in future studies. Thirdly, it was not easy to categorize our PLE patients into three subgroups because some patients had >2 haemodynamic abnormalities although, for convenience' sake, our categorizations were based on the complications that had come first.
CONCLUSIONS
The pre-PLE haemodynamics was characterized by high values of CVP and pulmonary resistance, low values of aortic pressure, arterial oxygen saturation and EF, while those after PLE only by a low systemic pressure. Functional one-lung circulation before the Fontan operation and a high early postoperative CVP predicted a new onset of PLE. Thus, in addition to an appropriate patient selection, aggressive strategies to decrease the CVP may be effective in preventing the onset of PLE with a high CVP, even if they are clinically stable. In addition, we should be aware that Fontan haemodynamics significantly changes before and after the PLE managements.
